Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers

NCT00750282 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Amyloid Beta-Protein

Interventions

DRUG: Florbetaben (BAY94-9172)

Sponsor

Life Molecular Imaging SA